Bad Science and Drug Price Caps: Orkambi and New York Medicaid

Bad Science and Drug Price Caps: Orkambi and New York Medicaid

Despite some notable improvements to the healthcare system over the last few years, American families and workers still struggle with annual cost increases that, on average, outpace wage growth and annual medical inflation rates. The COVID pandemic and the ongoing...
Draft Evidence Report on treatments for high cholesterol

Draft Evidence Report on treatments for high cholesterol

On November 12, 2020, ICER released its Draft Evidence Report entitled, “Bempedoic Acid and Inclisiran for Patients with Heterozygous Familial Hypercholesterolemia and for Secondary Prevention of ASCVD: Effectiveness and Value.”  Patients Rising Now submitted comments...
Draft Evidence Report on treatments for Hemophilia A

Draft Evidence Report on treatments for Hemophilia A

On August 26, 2020, ICER released its Draft Evidence Report entitled, “Valoctocogene Roxaparvovec and Emicizumab for Hemophilia A.”  Patients Rising Now submitted comments on the draft report raising a number of concerns about both the substance of the...